The @fda.gov has expanded the approval of Cablivi® to include treatment of pediatric patients 12 years and older with #aTTP, in combination with plasma exchange and immunosuppressive therapy. From @medicalprofref.bsky.social.
https://bit.ly/4aTlSbu
#TTPawareness #iTTP #thrombosis
#Daratumumab is safe and effective in allowing patients with #iTTP to achieve ADAMTS13 remission. Presented at #ASH25.
https://bit.ly/48HbIb9
Congratulations 👏👏 to @mimrobert.bsky.social for this very nice work 🗞
It seems worthy to look at anti-13 antibody during the follow-up of #iTTP . Maybe to guide anti-CD20 therapy ?
#Medsky
@amjh.bsky.social
onlinelibrary.wiley.com/doi/10.1002/...
📰 #iTTP is a rare disease that primarily affects individuals aged 20-40 years. Authors show results indicate caplacizumab is effective in reducing refractoriness, risk of death & likelihood of exacerbations in elderly patients, similar to outcomes observed in younger patients 👉https://bit.ly/42h2a4H
📖HemaSphere's April issue is now complete 👉 bit.ly/4dgFN3r and as always, is 100% #OpenAccess. Please enjoy reading these 21 quality papers & feel free to share with your networks. #hematology #research #LiverIron #QoL #EHAGuidelines #lymsm #hematopoiesis #iTTP #mmsm
Enough to stop him dead.
#intothepit #ittp #fnaf #pitbonnie